Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Effect of Golimumab treatment on work productivity and activity and quality of life in patients with Rheumatoid Arthritis, Psoriasis Arthritis and Axial Spondyloarthritis

Trial Profile

Effect of Golimumab treatment on work productivity and activity and quality of life in patients with Rheumatoid Arthritis, Psoriasis Arthritis and Axial Spondyloarthritis

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 24 Oct 2018

At a glance

  • Drugs Golimumab (Primary)
  • Indications Psoriatic arthritis; Rheumatoid arthritis
  • Focus Therapeutic Use
  • Acronyms Go Active
  • Most Recent Events

    • 24 Oct 2018 Interim results presented at the 82nd American College of Rheumatology and the 52nd Association of Rheumatology Health Professionals Annual Scientific Meeting
    • 16 Jul 2018 New trial record
    • 16 Jun 2018 Interim results (n=167) presented at the 19th Annual Congress of the European League Against Rheumatism.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top